Clearmind Medicine Inc. (CMND) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

Clearmind Medicine Inc.

NASDAQ: CMND · Real-Time Price · USD
1.04
0.02 (1.91%)
At close: Sep 05, 2025, 3:53 PM
1.04
0.00%
After-hours: Sep 05, 2025, 07:57 PM EDT

Clearmind Medicine Income Statement

Financials in USD. Fiscal year is November - October.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Oct 31, 2024 Oct 31, 2023 Oct 31, 2022 Oct 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a 56.34K 113.38K 2.57K
Gross Profit
-26.7K -56.34K -113.38K -2.57K
Operating Income
-8M -8.74M -8.53M -3.68M
Interest Income
271.22K 57.97K n/a n/a
Pretax Income
-4.88M -11.93M -9.37M -3.72M
Net Income
-5.25M -11.96M -9.41M -3.72M
Selling & General & Admin
4.35M 6.6M 5.43M 3.03M
Research & Development
1.38M 2.14M 2.98M 646.49K
Other Expenses
2.27M n/a 113.38K n/a
Operating Expenses
8M 8.74M 8.53M 3.68M
Interest Expense
36.16K n/a 19.68K n/a
Selling & Marketing Expenses
1.09M n/a n/a n/a
Cost & Expenses
8M 8.74M 8.53M 3.68M
Income Tax Expense
377.97K 24.09K 40.75K n/a
Shares Outstanding (Basic)
4.27M 2.02M 433.34K 309.11K
Shares Outstanding (Diluted)
4.27M 2.02M 433.34K 309.11K
EPS (Basic)
-1.69 -42.58 -168.61 -120.3
EPS (Diluted)
-1.69 -42.58 -217.2 -120.3
EBITDA
-7.98M -8.71M -8.49M -3.67M
EBIT
-8M -8.74M -8.52M -3.69M
Depreciation & Amortization
16.78K 30.69K 30.52K 2.57K